Category: Tysabri

ClinicSpeak & NeuroSpeak: sequencing DMTs switching from natalizumab to alemtuzumab

                                       …

Stuart Schlossman

ClinicSpeak: natalizumab or alemtuzumab?

                                       …

Stuart Schlossman

NATALIZUMAB MISSES ENDPOINT IN SECONDARY PROGRESSIVE MS

                                       …

Stuart Schlossman

Tysabri No Help in SPMS – Drug didn’t reduce disability progression but may benefit upper limb function

                                       …

Stuart Schlossman

EMA advocates more regular MRIs for MS patients on Biogen’s mAb Tysabri

By Gareth MacDonald+, 17-Feb-2016 Multiple sclerosis patients taking Tysabri (natalizumab) who are deemed to be at high risk for the lethal…

Stuart Schlossman

MS Neurologist Argues for Continued Use of Natalizumab as Disease Treatment

In a recent study of more than 1,200 patients with multiple sclerosis (MS), a research team reported that treatment with the…

Stuart Schlossman

Study Shows That People with MS Taking Natalizumab Develop Antibodies to the JC Virus at Higher Than Normal Rates, Emphasizing Need for Regular Monitoring

January 27, 2016 A study by researchers in Germany and France observed changes in JC virus antibody status in two…

Stuart Schlossman

Natalizumab ( Tysabri ) Reported To Be a Safe and Effective Therapy for Pediatric Multiple Sclerosis

October 1, 2015 A new study recently published in the journal BMC Neurology revealed that natalizumab (TYSABRI) is a safe…

Stuart Schlossman

Possible JC Virus Vaccination Offers Important Implications for MS Treatment

Two studies recently published in the journal Science Translational Medicine, revealed a possible new vaccine treatment for JC virus with important…

Stuart Schlossman

New Mouse Model Better Represents JC Virus That Infects MS Patients

Posted by: Maureen Newman   November 24, 2014 Researchers in the laboratory of Steve Goldman, MD, PhD, Co-Director of University…

Stuart Schlossman

Categories

Latest Blog Posts